| abstract |
The invention provides a method of reducingnpostoperative complications of cardiopulmonary bypassn(CPB) surgery in which an effective amount of a methylolntransfer agent, such as taurolidine, is administered tona patient in conjunction with CPB surgery. Patientsnundergoing crystalloid cardioplegia who were treatednwith taurolidine showed reduced levels of IL-6 andnincreased levels of IL-10 when compared to crystalloidnpatients administered a placebo. |